Cargando…
胸腔注射榄香烯致严重不良反应7例病例系列分析
BACKGROUND AND OBJECTIVE: Malignant pleural effusion (MPE) refers to pleural effusion which arises from primary malignant tumor of pleura or other pleural metastatic tumors. Injection of elemene in chest makes good effect on the treatment of MPE, and is widely used in clinic. Adverse effects also ex...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022031/ https://www.ncbi.nlm.nih.gov/pubmed/29945704 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.06.06 |
_version_ | 1783335590037553152 |
---|---|
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: Malignant pleural effusion (MPE) refers to pleural effusion which arises from primary malignant tumor of pleura or other pleural metastatic tumors. Injection of elemene in chest makes good effect on the treatment of MPE, and is widely used in clinic. Adverse effects also exist, but the severe adverse effects and relevant managements are rarely reported. The aim of this study is to observe the adverse reactions induced by the treatment of malignant pleural effusion through elemene injection and to explore the solutions. METHODS: A retrospective analysis was made on 14 cases of patients receiving intra-pleural injections with elemene, and the incidence of severe adverse reactions of 7 cases were disscussed in detail. RESULTS: Most of the severe adverse reactions caused by elemene were severe chest pain, dyspnea, wheezing, clouding of consciousness and coagulopathy. CONCLUSION: Strict screening, full preprocessing and close monitoring are necessary to prevent serious adverse reactions caused by elemene injection in the treatment of malignant pleural effusion. |
format | Online Article Text |
id | pubmed-6022031 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60220312018-07-06 胸腔注射榄香烯致严重不良反应7例病例系列分析 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: Malignant pleural effusion (MPE) refers to pleural effusion which arises from primary malignant tumor of pleura or other pleural metastatic tumors. Injection of elemene in chest makes good effect on the treatment of MPE, and is widely used in clinic. Adverse effects also exist, but the severe adverse effects and relevant managements are rarely reported. The aim of this study is to observe the adverse reactions induced by the treatment of malignant pleural effusion through elemene injection and to explore the solutions. METHODS: A retrospective analysis was made on 14 cases of patients receiving intra-pleural injections with elemene, and the incidence of severe adverse reactions of 7 cases were disscussed in detail. RESULTS: Most of the severe adverse reactions caused by elemene were severe chest pain, dyspnea, wheezing, clouding of consciousness and coagulopathy. CONCLUSION: Strict screening, full preprocessing and close monitoring are necessary to prevent serious adverse reactions caused by elemene injection in the treatment of malignant pleural effusion. 中国肺癌杂志编辑部 2018-06-20 /pmc/articles/PMC6022031/ /pubmed/29945704 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.06.06 Text en 版权所有©《中国肺癌杂志》编辑部2018 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 临床研究 胸腔注射榄香烯致严重不良反应7例病例系列分析 |
title | 胸腔注射榄香烯致严重不良反应7例病例系列分析 |
title_full | 胸腔注射榄香烯致严重不良反应7例病例系列分析 |
title_fullStr | 胸腔注射榄香烯致严重不良反应7例病例系列分析 |
title_full_unstemmed | 胸腔注射榄香烯致严重不良反应7例病例系列分析 |
title_short | 胸腔注射榄香烯致严重不良反应7例病例系列分析 |
title_sort | 胸腔注射榄香烯致严重不良反应7例病例系列分析 |
topic | 临床研究 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022031/ https://www.ncbi.nlm.nih.gov/pubmed/29945704 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.06.06 |
work_keys_str_mv | AT xiōngqiāngzhùshèlǎnxiāngxīzhìyánzhòngbùliángfǎnyīng7lìbìnglìxìlièfēnxī AT xiōngqiāngzhùshèlǎnxiāngxīzhìyánzhòngbùliángfǎnyīng7lìbìnglìxìlièfēnxī AT xiōngqiāngzhùshèlǎnxiāngxīzhìyánzhòngbùliángfǎnyīng7lìbìnglìxìlièfēnxī AT xiōngqiāngzhùshèlǎnxiāngxīzhìyánzhòngbùliángfǎnyīng7lìbìnglìxìlièfēnxī AT xiōngqiāngzhùshèlǎnxiāngxīzhìyánzhòngbùliángfǎnyīng7lìbìnglìxìlièfēnxī |